AXON

Axon Enterprise, Inc.

Fundamental data last updated:June 14, 2026

We may earn a commission from partner links. This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate.

company profile

SECTOR

Industrials

industry

Aerospace & Defense

Exchange

NASDAQ

County of HQ

US

Next Earnings Date

08/03/2026

Business Summary

Axon Enterprise, Inc. develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, TASER, and Software and Sensors. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence. Its products include TASER 7, TASER X26P, TASER X2, TASER Consumer devices, and related cartridges; on-officer body cameras, Axon Fleet in-car systems, and other devices; Axon Evidence digital evidence management software; Axon Signal enabled devices, as well as hardware extended warranties; and Axon docks, cartridges, and batteries. It sells its products through its direct sales force, distribution partners, online store, and third-party resellers. Axon Enterprise, Inc. has a strategic partnership with Fusus, Inc. to expand the capabilities of Axon Respond and the Fusus Real Time Crime Center in the Cloud solution to provide agencies real-time operations situational awareness, including streamlined investigative workflows. The company was formerly known as TASER International, Inc. and changed its name to Axon Enterprise, Inc. in April 2017. Axon Enterprise, Inc. was incorporated in 1993 and is headquartered in Scottsdale, Arizona.

 


VALUATION

P/E

172.63

Market Cap ($M USD)

$35.81B

Forward P/E

31.97

PEG

0.07

PRICE TO SALES

12.01

PRICE TO BOOK

10.08

EV / EBITDA

193.08

5-Year Average P/E

Free Cash Flow Yield

0.05%

DCF Value

$-92.52

Graham Number

$50.53

Price to FCF

1836.24

EV to FCF

1906.43

Earnings Yield

0.58%

FCF Yield

0.05%

DIVIDEND

Yield

0.00%

Annual Payout

$0.00

Payout Ratio

0.00%

Consecutive Years of Dividend Growth

5-Year Dividend Growth Rate

Financial Health & Profitability

Earnings Per Share

$2.57

Next Year EPS Growth Estimate

$13.89

Next Year Revenue Growth Estimate

$608.11B

Return on Equity (ROE)

6.58%

FREE CASH FLOW

Operating Margin

1.48%

Debt-to-Equity

0.59

Piotroski F-Score

3

Altman Z-Score

6.31

Return on Invested Capital (ROIC)

0.75%

Current Ratio

2.27

Quick Ratio

1.93

Net Debt to EBITDA

7.11

Interest Coverage

0.38

Gross Profit margin

59.32%

FCF PER SHARE

$0.24

REVENUE PER SHARE

$37.22

Gainseekers Quantitative Analysis

Summary

Axon Enterprise, Inc. is priced for perfection, with a staggering Price/Earnings ratio of 156.82, suggesting the market expects extraordinary growth. Yet, the DCF Value paints a grim picture, indicating the stock traded significantly above its intrinsic value. The Forward P/E of 29.04 offers a glimmer of hope for future earnings growth, but the Earnings Yield of 0.64% is underwhelming. Despite a robust Altman Z-score of 6.47, signaling financial stability, the valuation metrics suggest a disconnect between market expectations and fundamental value.

AI Exposure / Tech Reliance

Operating within the Aerospace & Defense sector, Axon is well-positioned to leverage AI advancements. Its focus on technology-driven solutions aligns with industry trends, enhancing its adaptability. This positioning could bolster its resilience against tech disruptions.

The Bull Case

For the discerning GARP investor, Axon presents a compelling narrative of potential growth. The Forward PEG ratio of 0.066 indicates undervaluation relative to expected growth. Despite a modest ROIC of 0.65%, the company's ability to maintain a Current Ratio of 2.27 suggests solid liquidity. While the Piotroski F-Score of 3 is mediocre, the Gross Profit Margin of 59.32% highlights strong pricing power, hinting at efficient capital deployment.

The Bear Case

Axon's valuation metrics are a glaring red flag for cautious investors. The Price/Book ratio of 9.15 and Price/Sales of 10.90 suggest the stock is significantly overvalued. With an EV to EBITDA of 175.98, the company appears stretched, especially given its negligible FCF Yield of 0.06%. The technical overextension near its 52-week high further amplifies the risk of a correction.

Market Sentiment & Smart Money

Short Interest %

Analyst Consensus

Buy

Average Analyst Price Target

$653.89

Institutional Ownership %

1-Year Beta

1.44

Insider Buying % (6 Mo)

Distance to 52-Week High

99.43%

Distance to 52-Week Low

23.68%

EARNINGS SURPRISE %

0.63%

50-DAY SMA

$408.67

200-DAY SMA

$567.35

⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.